West Pharmaceutical Services, Inc.
DE ˙ DB ˙ GB00BLGXWY71
269,50 € ↑3,00 (1,13%)
2026-06-04
DEL PRIS
SecurityDE:WPS / West Pharmaceutical Services, Inc.
InstitutionPoint72 Asset Management, L.P.
ManagerSteven Cohen
Latest Disclosed Ownership159,350 shares
Latest Disclosed Value $ 39,939,484
Point72 Asset Management, L.P. ownership in WPS / West Pharmaceutical Services, Inc.

On May 15, 2026 - Point72 Asset Management, L.P. filed a 13F-HR form disclosing ownership of 159,350 shares of West Pharmaceutical Services, Inc. (DE:WPS) valued at $34,021,225 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 17, 2026 disclosing 235,037 shares of West Pharmaceutical Services, Inc.. This represents a change in shares of -32.20% during the quarter. The current value of the position is $42,944,825 USD.

Point72 Asset Management, L.P. has a history of taking positions in derivatives of the underlying security (WPS) in the form of stock options. The firm currently holds call options representing 0 of underlying shares valued at $0 USD and put options representing 387,100 of underlying shares valued at $97,022,744 USD .

Note: prior versions of this page mistakenly stated that the share values represented the number of options, not the number of underlying shares. For more information on the data backing these reports, please see the SEC document Frequently Asked Questions About Form 13F.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Institutional Put/Call Ratios
(Premium Subscription Required)

In addition to reporting standard equity and debt issues, institutions with more than 100MM assets under management must also disclose their put and call option holdings. Since put options generally indicate negative sentiment, and call options indicate positive sentiment, we can get a sense of the overall institutional sentiment by plotting the ratio of puts to calls. The chart to the right plots the historical put/call ratio for this instrument.

Using Put/Call Ratio as an indicator of investor sentiment overcomes one of the key deficiencies of using total institutional ownership, which is that a significant amount of assets under management are invested passively to track indices. Passively-managed funds do not typically buy options, so the put/call ratio indicator more closely tracks the sentiment of actively-managed funds.

DE:WPS / West Pharmaceutical Services, Inc. Historical Put/Call Ratio
Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-15 2026-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 159,350 -75,687 -32.20 39,939 -38.24 0.0512
2026-02-17 2025-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 235,037 -424,216 -64.35 64,668 -62.61 0.0723
2025-11-14 2025-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 659,253 319,300 93.92 172,942 132.51 0.2894
2025-08-14 2025-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 339,953 211,666 164.99 74,382 158.99 0.1460
2025-07-21 2025-03-31 13F/A-1 WEST PHARMACEUTICAL SVSC COM 955306105 128,287 -74,185 -36.64 28,721 -56.70 0.0656
2025-05-15 2025-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 128,287 -74,185 28,721 0.0656
2025-02-14 2024-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 202,472 202,472 66,322 0.1461
2024-09-16 2024-06-30 13F/A-2 WEST PHARMACEUTICAL SVSC COM 955306105 0 -112,107 -100.00 0 -100.00
2024-08-19 2024-06-30 13F/A-1 WEST PHARMACEUTICAL SVSC COM 955306105 0 -112,107 0
2024-08-14 2024-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 0 0
2024-05-15 2024-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 112,107 4,516 4.20 44,362 17.10 0.1075
2024-02-14 2023-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 107,591 -76,000 -41.40 37,885 -45.00 0.0916
2023-11-14 2023-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 183,591 183,591 68,885 0.2010
2023-08-14 2023-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 0 -174,599 -100.00 0 -100.00
2023-05-15 2023-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 174,599 174,065 32,596.44 60,493 48,294.40 0.1874
2023-05-15 2022-12-31 13F/A-1 WEST PHARMACEUTICAL SVSC COM 955306105 534 534 126 0.0004
2023-02-14 2022-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 534 534 126 0.0004
2022-02-14 2021-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 0 -24,728 -100.00 0 -100.00
2021-11-15 2021-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 24,728 -5,400 -17.92 10,498 -2.97 0.0461
2021-08-16 2021-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 30,128 -16,729 -35.70 10,819 -18.06 0.0486
2021-05-17 2021-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 46,857 8,739 22.93 13,203 22.26 0.0617
2021-02-16 2020-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 38,118 -23,591 -38.23 10,799 -36.34 0.0527
2020-11-16 2020-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 61,709 -9,588 -13.45 16,964 4.74 0.0869
2020-08-14 2020-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 71,297 41,316 137.81 16,197 254.81 0.1056
2020-05-15 2020-03-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 29,981 -97,212 -76.43 4,565 -76.13 0.0371
2020-02-14 2019-12-31 13F WEST PHARMACEUTICAL SVSC COM 955306105 127,193 90,195 243.78 19,121 264.42 0.1005
2019-11-15 2019-09-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 36,998 35,798 2,983.17 5,247 3,398.00 0.0322
2019-08-14 2019-06-30 13F WEST PHARMACEUTICAL SVSC COM 955306105 1,200 1,200 150 0.0008
Disclosed Call Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share
Price
Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F WEST PHARMACEUTICAL SVSC COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2026-02-17 2025-12-31 13F WEST PHARMACEUTICAL SVSC COM Call 1,200 330 n/a n/a n/a
2024-09-16 2024-06-30 13F/A WEST PHARMACEUTICAL SVSC COM Call 0 -100.00 0 -100.00 n/a n/a n/a
2024-08-19 2024-06-30 13F/A WEST PHARMACEUTICAL SVSC COM Call 0 0 n/a n/a n/a
2024-08-14 2024-06-30 13F WEST PHARMACEUTICAL SVSC COM Call 0 0 n/a n/a n/a
2024-05-15 2024-03-31 13F WEST PHARMACEUTICAL SVSC COM Call 20,000 7,914 n/a n/a n/a
Disclosed Put Options
File
Date
Effective
Date
Form Security Class ID Opt Avg Share Price Shares ΔShares
(%)
Value
(x1000)
ΔValue
(%)
Prior Allocation
(%)
Allocation
(%)
ΔAllocation
(%)
Cost Basis
(x1000)
Profit
(x1000)
Return
(%)
2026-05-15 2026-03-31 13F WEST PHARMACEUTICAL SVSC COM Put 387,100 24,093.75 97,023 21,950.45 n/a n/a n/a
2026-02-17 2025-12-31 13F WEST PHARMACEUTICAL SVSC COM Put 1,600 440 n/a n/a n/a
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.